11/14/2024 5:05 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2024 5:29 PM | BeiGene (Filed by) LEAP THERAPEUTICS, INC. (Subject)
| Form SC 13D/A | |
10/31/2024 4:40 PM | BeiGene (Filed by) LEAP THERAPEUTICS, INC. (Subject)
| Form SCHEDULE 13D/A | |
10/28/2024 5:05 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2024 4:48 PM | BeiGene (Issuer) OYLER JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/08/2024 3:23 PM | BeiGene (Subject) OYLER JOHN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024 3:24 PM | BeiGene (Subject) OYLER JOHN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/02/2024 6:13 PM | BeiGene (Issuer) Lee Chan Henry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/02/2024 6:16 PM | BeiGene (Issuer) Sharp Shalini (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/02/2024 6:21 PM | BeiGene (Issuer) Sharp Shalini (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 5:29 PM | BeiGene (Issuer) Wang Lai (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 3:27 PM | BeiGene (Subject) Lee Chan Henry (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024 5:02 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2024 5:12 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2024 4:25 PM | BeiGene (Issuer) Wu Xiaobin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/17/2024 3:40 PM | BeiGene (Subject) Wu Xiaobin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024 4:40 PM | Ball Titus B. (Reporting) BeiGene (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 4:41 PM | BeiGene (Issuer) Wu Xiaobin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 3:19 PM | BeiGene (Subject) Wu Xiaobin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024 6:29 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/27/2024 3:30 PM | BeiGene (Subject) OYLER JOHN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024 4:27 PM | BeiGene (Issuer) Wang Xiaodong (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/13/2024 4:17 PM | BeiGene (Issuer) Rosenberg Aaron (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/07/2024 6:32 AM | BeiGene (Filer)
| Form S-4 Registration statement under Securities Act of 1933 | |
08/07/2024 5:04 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 5:07 AM | BeiGene (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024 4:06 PM | BeiGene (Issuer) Lee Chan Henry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 4:23 PM | BeiGene (Issuer) Rosenberg Aaron (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/18/2024 5:40 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2024 4:05 PM | BeiGene (Issuer) Wang Julia Aijun (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 3:18 PM | BeiGene (Subject) Wang Julia Aijun (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024 4:22 PM | BeiGene (Issuer) OYLER JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 4:24 PM | BeiGene (Issuer) Wu Xiaobin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 4:25 PM | BeiGene (Issuer) Wang Lai (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 4:26 PM | BeiGene (Issuer) Wang Julia Aijun (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2024 3:30 PM | BeiGene (Subject) OYLER JOHN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 3:19 PM | BeiGene (Subject) Wang Julia Aijun (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 3:23 PM | BeiGene (Subject) Wu Xiaobin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 3:25 PM | BeiGene (Subject) Wang Lai (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024 4:27 PM | BeiGene (Issuer) OYLER JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:24 PM | BeiGene (Issuer) Lee Chan Henry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
There is a little known company that is changing warfare (Ad) With geo - political instability around the world investors are flocking to defense contract stocks.
There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t |
06/20/2024 4:25 PM | BeiGene (Issuer) Wu Xiaobin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:25 PM | BeiGene (Issuer) Wang Lai (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:26 PM | BeiGene (Issuer) Wang Julia Aijun (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2024 3:50 PM | BeiGene (Subject) Wang Lai (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 3:50 PM | BeiGene (Subject) Wang Lai (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 3:53 PM | BeiGene (Subject) OYLER JOHN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024 3:57 PM | BeiGene (Subject) Wang Julia Aijun (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 4:01 PM | BeiGene (Issuer) BRANDICOURT OLIVIER (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:02 PM | BeiGene (Issuer) Dugan Margaret (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:03 PM | BeiGene (Issuer) Lee Chan Henry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:03 PM | BeiGene (Issuer) Wang Lai (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:04 PM | BeiGene (Issuer) Wu Xiaobin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 4:05 PM | Ball Titus B. (Reporting) BeiGene (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 3:31 PM | BeiGene (Issuer) Yi Qingqing (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 4:23 PM | BeiGene (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/05/2024 3:35 PM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2024 3:25 PM | BeiGene (Subject) OYLER JOHN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024 5:06 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 5:09 AM | BeiGene (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024 3:21 PM | BeiGene (Filer)
| Form ARS | |
04/26/2024 3:16 PM | BeiGene (Filer)
| Form DEF 14A | |
04/26/2024 6:15 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 3:13 PM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/15/2024 3:27 PM | BeiGene (Filer)
| Form PRE 14A | |
04/11/2024 5:01 PM | BeiGene (Issuer) OYLER JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/09/2024 3:21 PM | BeiGene (Subject) OYLER JOHN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024 4:26 PM | Ball Titus B. (Reporting) BeiGene (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
03/20/2024 3:10 PM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/14/2024 4:23 PM | BeiGene (Issuer) OYLER JOHN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 4:04 PM | BeiGene (Issuer) Glazer Donald W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 5:01 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 5:16 AM | BeiGene (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/26/2024 5:02 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/05/2024 3:12 PM | BeiGene (Subject) OYLER JOHN (Filed by)
| Form SC 13G/A | |
01/23/2024 5:03 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 5:01 AM | BeiGene (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2023 4:44 PM | BeiGene (Issuer) Wang Xiaodong (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |